JP2023528896A5 - - Google Patents
Info
- Publication number
- JP2023528896A5 JP2023528896A5 JP2022574676A JP2022574676A JP2023528896A5 JP 2023528896 A5 JP2023528896 A5 JP 2023528896A5 JP 2022574676 A JP2022574676 A JP 2022574676A JP 2022574676 A JP2022574676 A JP 2022574676A JP 2023528896 A5 JP2023528896 A5 JP 2023528896A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- determined
- treatment
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025156736A JP2025183391A (ja) | 2020-06-05 | 2025-09-22 | トゥレット症候群の治療のためのホスホジエステラーゼ１０阻害剤の使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063035310P | 2020-06-05 | 2020-06-05 | |
| US63/035,310 | 2020-06-05 | ||
| US202163160302P | 2021-03-12 | 2021-03-12 | |
| US63/160,302 | 2021-03-12 | ||
| PCT/EP2021/065074 WO2021245280A1 (en) | 2020-06-05 | 2021-06-04 | Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025156736A Division JP2025183391A (ja) | 2020-06-05 | 2025-09-22 | トゥレット症候群の治療のためのホスホジエステラーゼ１０阻害剤の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023528896A JP2023528896A (ja) | 2023-07-06 |
| JP2023528896A5 true JP2023528896A5 (https=) | 2024-06-12 |
| JP7748974B2 JP7748974B2 (ja) | 2025-10-03 |
Family
ID=76325557
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574676A Active JP7748974B2 (ja) | 2020-06-05 | 2021-06-04 | トゥレット症候群の治療のためのホスホジエステラーゼ１０阻害剤の使用 |
| JP2025156736A Pending JP2025183391A (ja) | 2020-06-05 | 2025-09-22 | トゥレット症候群の治療のためのホスホジエステラーゼ１０阻害剤の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025156736A Pending JP2025183391A (ja) | 2020-06-05 | 2025-09-22 | トゥレット症候群の治療のためのホスホジエステラーゼ１０阻害剤の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11883385B2 (https=) |
| EP (1) | EP4161526A1 (https=) |
| JP (2) | JP7748974B2 (https=) |
| KR (2) | KR20250171459A (https=) |
| CN (2) | CN116137811B (https=) |
| AU (1) | AU2021285225A1 (https=) |
| BR (1) | BR112022024751A2 (https=) |
| CA (1) | CA3180793A1 (https=) |
| CL (2) | CL2022003400A1 (https=) |
| IL (1) | IL298713A (https=) |
| MX (1) | MX2022015400A (https=) |
| PH (1) | PH12023550007A1 (https=) |
| WO (1) | WO2021245280A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12544364B2 (en) * | 2020-06-05 | 2026-02-10 | Noema Pharma Ag | Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome |
| WO2022162193A1 (en) * | 2021-01-28 | 2022-08-04 | Noema Pharma Ag | Methods for the treatment of childhood-onset fluency disorder |
| WO2026068583A1 (en) * | 2024-09-25 | 2026-04-02 | Noema Pharma Ag | Use of phosphodiesterase 10 inhibitor gemlapodect for weight loss |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605897A (en) * | 1991-04-23 | 1997-02-25 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine |
| US20030032579A1 (en) * | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
| EP1723134A2 (en) * | 2004-02-18 | 2006-11-22 | Pfizer Products Incorporated | Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline |
| US7786139B2 (en) * | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| US8349824B2 (en) * | 2010-12-07 | 2013-01-08 | Hoffmann-La Roche Inc. | Triazolopyridine compounds |
| BR112014004310B8 (pt) * | 2011-08-25 | 2023-04-18 | Merck Sharp & Dohme | Composto de pirimidina inibidor da enzima fosfodiesterase 10, composição farmacêutica, uso de um composto |
| PL3919060T3 (pl) * | 2012-07-12 | 2025-10-20 | Emalex Biosciences, Inc. | Ekopipam do leczenia zespołu tourette'a |
| NZ708593A (en) * | 2013-02-27 | 2018-01-26 | Mochida Pharm Co Ltd | Novel pyrazole derivative |
| MY169128A (en) * | 2013-04-30 | 2019-02-18 | Hoffmann La Roche | Pd-catalyzed coupling of pyrazole amides |
-
2021
- 2021-06-04 CN CN202180057821.7A patent/CN116137811B/zh active Active
- 2021-06-04 IL IL298713A patent/IL298713A/en unknown
- 2021-06-04 MX MX2022015400A patent/MX2022015400A/es unknown
- 2021-06-04 CA CA3180793A patent/CA3180793A1/en active Pending
- 2021-06-04 JP JP2022574676A patent/JP7748974B2/ja active Active
- 2021-06-04 WO PCT/EP2021/065074 patent/WO2021245280A1/en not_active Ceased
- 2021-06-04 KR KR1020257039481A patent/KR20250171459A/ko active Pending
- 2021-06-04 EP EP21730917.8A patent/EP4161526A1/en active Pending
- 2021-06-04 AU AU2021285225A patent/AU2021285225A1/en active Pending
- 2021-06-04 BR BR112022024751A patent/BR112022024751A2/pt unknown
- 2021-06-04 PH PH1/2023/550007A patent/PH12023550007A1/en unknown
- 2021-06-04 KR KR1020237000369A patent/KR102892626B1/ko active Active
- 2021-06-04 CN CN202511962745.0A patent/CN121891333A/zh active Pending
-
2022
- 2022-12-01 CL CL2022003400A patent/CL2022003400A1/es unknown
- 2022-12-02 US US18/061,206 patent/US11883385B2/en active Active
-
2025
- 2025-08-29 CL CL2025002636A patent/CL2025002636A1/es unknown
- 2025-09-22 JP JP2025156736A patent/JP2025183391A/ja active Pending
- 2025-11-25 US US19/401,292 patent/US20260076950A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021229240B2 (en) | Compositions comprising 2-((1-(2(4-Fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one for treating schizophrenia | |
| CN116650500B (zh) | 治疗癌症的方法 | |
| US20120157472A1 (en) | Method for treating colorectal cancer | |
| JP2023528896A5 (https=) | ||
| JP6154878B2 (ja) | アタザナビルを含む錠剤組成物 | |
| EA034992B1 (ru) | Комбинации лекарственных средств для лечения множественной миеломы | |
| JP2017510607A (ja) | Ｓ１ｐ調節剤即時放出投与レジメン | |
| JP2010530889A (ja) | アタザナビルを含む錠剤組成物 | |
| JP6068765B2 (ja) | 薬学的複合製剤 | |
| JP2010530892A (ja) | アタザナビルを含む錠剤組成物 | |
| JP2022536623A (ja) | 肺動脈性肺高血圧症の治療方法 | |
| CN114126712A (zh) | 无定形司巴森坦（sparsentan）组合物 | |
| EP2814493A2 (en) | Combinations of histone deacetylase inhibitor and pazopanib and uses thereof | |
| WO2018115888A1 (en) | Novel formulations of aprepitant | |
| CN112584834B (zh) | 用于治疗结外nk/t细胞淋巴瘤的喹啉衍生物 | |
| JP2010530890A (ja) | アタザナビルを含む錠剤組成物 | |
| CN102836161A (zh) | 一种以奥美沙坦酯与苯磺酸氨氯地平及氢氯噻嗪混合组成的药物的复方制剂 | |
| JP2024505515A5 (https=) | ||
| WO2018211336A2 (en) | Solid dosage form containing sorafenib tosylate | |
| JP2003513888A (ja) | 神経疾患治療用医薬品 | |
| JP6995479B2 (ja) | 発泡剤を含む抗微生物組成物 | |
| JP2023533903A (ja) | Ｆｇｆｒ４阻害剤の経口製剤によるがんの治療方法 | |
| KR20260019468A (ko) | 위식도 역류 질환(gerd) 치료를 위한 리나프라잔 글루레이트 | |
| JP2002518330A (ja) | 処置方法 | |
| CA3071096A1 (en) | Co-administration of minocycline and colistin to reduce acute kidney injury |